![Ellen Baron](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 30/09/2026
Ellen S.
Baron currently works at TetraGenetics, Inc., as Chairman, OPKO Diagnostics LLC, as Director, Outcome Capital LLC, as Managing Director from 2017, and PainReform Ltd., as Independent External Director from 2020.
Dr. Baron also formerly worked at Applied Spine Technologies, Inc., as Director, BrainCells, Inc., as Director, AbCellera Boston, Inc., as Director from 2019 to 2021, Third500 LLC, as Managing Director from 2012 to 2017, Sixth Element Capital LLP, as Independent Director, Human Genome Sciences, Inc., as Senior Vice President-Business Development, and Oxford Bioscience Partners, as Partner.
Dr. Baron received her undergraduate degree from Goucher College and doctorate degree from Georgetown University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 18/03/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PRF TECHNOLOGIES LTD. | Director/Miembro de la Junta | 01/09/2020 |
OPKO Diagnostics LLC
 OPKO Diagnostics LLC Medical/Nursing ServicesHealth Services Provides health services | Director/Miembro de la Junta | 15/09/2009 |
Outcome Capital LLC
 Outcome Capital LLC Investment Banks/BrokersFinance Operates as investment banking firm | Corporate Officer/Principal | 01/02/2017 |
| Empresas | Cargo | Fin |
|---|---|---|
AbCellera Boston, Inc.
 AbCellera Boston, Inc. BiotechnologyHealth Technology Produces vaccines for plant, animal and human diseases | Director/Miembro de la Junta | 13/09/2021 |
Healthios Capital Markets LLC
 Healthios Capital Markets LLC Investment ManagersFinance Provides financial advisory services | Corporate Officer/Principal | 01/01/2017 |
Sixth Element Capital LLP
 Sixth Element Capital LLP Investment ManagersFinance Sixth Element Capital invests in cancer and oncology drug discovery research projects across Europe. The firm provides financing for growth capital requirements with an investment up to £50 million. | Director/Miembro de la Junta | - |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Corporate Officer/Principal | - |
Applied Spine Technologies, Inc.
 Applied Spine Technologies, Inc. Medical SpecialtiesHealth Technology Provides medical treatment devices | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations. | Finance |
Applied Spine Technologies, Inc.
Applied Spine Technologies, Inc. Medical SpecialtiesHealth Technology Provides medical treatment devices | Health Technology |
BrainCells, Inc.
 BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
AbCellera Boston, Inc.
AbCellera Boston, Inc. BiotechnologyHealth Technology Produces vaccines for plant, animal and human diseases | Health Technology |
Goucher College
 Goucher College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Healthios Capital Markets LLC
Healthios Capital Markets LLC Investment ManagersFinance Provides financial advisory services | Finance |
OPKO Diagnostics LLC
OPKO Diagnostics LLC Medical/Nursing ServicesHealth Services Provides health services | Health Services |
Outcome Capital LLC
Outcome Capital LLC Investment Banks/BrokersFinance Operates as investment banking firm | Finance |
PainReform Ltd.
 PainReform Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceuticals for pain treatment | Health Technology |
Sixth Element Capital LLP
Sixth Element Capital LLP Investment ManagersFinance Sixth Element Capital invests in cancer and oncology drug discovery research projects across Europe. The firm provides financing for growth capital requirements with an investment up to £50 million. | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
